Pharmacophore development for corticotropin-releasing hormone: New insights into inhibitor activity

Journal of Medicinal Chemistry

Volumn 42, Issue 13, 1999, Pages 2351-2357

  Keller, Paul A ^a   Bowman, Maria ^c   Dang, Kor Hin ^a   Garner, James ^b   Leach, Scott P ^a   Smith, Roger ^c   McCluskey, Adam ^b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTALARMIN; BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; BINDING SITE; CHILDBIRTH; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DRUG SYNTHESIS; LABOR; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PHARMACOPHORE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BINDING SITES; CELL LINE; CORTICOTROPIN-RELEASING HORMONE; LIGANDS; MICE; MODELS, MOLECULAR; PYRIMIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033168446     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9900117     Document Type: Article

References (25)

1. Vale, W.; Spiess, C.; Rivier, C. Characterization of a 41-Residue Ovine Hypothalic Peptide that Stimulates Secretion of Corticotropin and β-Endorphin. Science 1981, 213, 1394-1397.
2. De Souza, E. B.; Lovenberg, T. W.; Chalmers, D. T.; Grigoriadis, D. E.; Liaw, C. W.; Behan, D. P.; McCarthy, J. R. Heterogeneity of Corticotropin Releasing Factor Receptors; Multiple Targets for the Treatment of CNS and Inflammatory Disorders. Annu. Rep. Med. Chem. 1995, 30, 21-30.
3. McClean, M.; Bisits, A.; Davies, J.; Lowry, P.; Smith, R. A Placental Clock Controlling the Length of Human Pregnancy. Nature Med. 1995, 1, 460-463.
4. McClean, M.; Walters, W. A.; Smith, R. Obstet. Gynecol. Surv. 1993, 48 (4), 209-225.
5. Smith, R.; Chan, E.-C.; Bowman, M. E.; Harewood, W. J.; Phippard, A. F. Corticotropin Releasing Hormone in Baboon Pregnancy. J. Clin. Endocrinol. Metab. 1993, 76 (4), 1063-1067.
6. Stalla, G. K.; Boat, H.; Stalla, J.; Kaliebe, T.; Dorr, H. G.; Pfeiffer, D. Human Corticotropin Releasing Hormone During Pregnacy. Gynecol. Endocrinol. 1989, 3, 1-10.
7. Wolfe, C. D. A.; Patel, S. P.; Campbell, E. A.; Linton, E. A.; Anderson, J.; Lowry, P. J. Plasma Corticotropin Releasing Factor in Normal Pregnacy. Br. J. Obstet. Gynaecol. 1988, 95, 997-1002.
8. Petraglia, F.; Giardino, L.; Coukos, G.; Calza, L.; Vale, W.; Genazzani, A. R. Corticotropin Releasing Hormone and Parturition: Plasma and Amniotic Fluid Levels and Placental Binding Sites. Obstet. Gynecol. 1990, 349, 423-426.
9. Sasaki, S.; Shinkawa, O.; Margioris, A. N.; Liotta, A. S.; Sato, S.; Murakami, O. Immunoreactive Corticotropin Releasing Hormone in Human Plasma During Pregnacy, Labour and Delivery. J. Clin. Endocrinol. Metab. 1987, 64, 224-229.
10. McClean, M.; Thompson, D.; Zhang, H. P.; Brinsmead, M.; Smith, R. Corticotropin Releasing Hormone and β-Endorphin in Labour. Eur. J. Endocrinol. 1994, 131, 167-172.
11. Chen, R.; Lewis, K. A.; Perrin, M. H.; Vale, W. Expression Cloning of a Human Corticotropin-Releasing-Factor Receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 8967-8971.
12. Asakura, H.; Zwain, I. H.; Yen, S. S. C. Expression of Genes Encoding Corticotropin-Releasing Factor (CRF), Type 1 CRF Receptor, and CRF-Binding Protein and Localization of the Gene Products in the Human Ovary. J. Clin. Endocrinol. Metab. 1997, 82 (8), 2720-2725.
13. Koerber, S. C.; Gulyas, J.; Lahrichi, S. L.; Corrigan, A.; Craig, A. C.; Rivier, C.; Vale, W.; Rivier, J. Constrained Corticotropin-Releasing Factor (CRF) Agonists and Antagonists with i-(i+3) Glu-Xaa-DXbb-Lys Bridges. J. Med. Chem. 1998, 41, 5002-5011.
14. Lovenberg, T. W.; Grigoriadis, D. E.; Chalmers, D. T.; McCarthy, J. R.; De Souza, E. B. Curr. Pharm. Des. 1995, 1, 305.
15. Schulz, D. W.; Mansbach, R. S.; Sprouse, J.; Braselton, J. P.; Collins, J.; Corman, M.; Duaiskis, A.; Faraci, S.; Schmidt, A. W.; Seeger, T.; Seymour, P.; Tingley, J. D., III; Winston, E. N.; Chen, Y. L.; Heym. CP-154,526 - A Potent and Selective Nonpeptide Antagonist of Corticotropin Releasing Factor Receptors. Proc. Natl. Acad, Sci. U.S.A. 1996, 93, 10477-10482.
16. Hernandez, J.-F.; Kornreich, W.; Rivier, C.; Miranda, A.; Yamamoto, G.; Andrews, J.; Tache, Y.; Vale, W.; Rivier, J. Synthesis and Relative Potencies of New Constrained CRF Antagonists. J. Med. Chem. 1993, 36, 2860-2867.
17. McCluskey, A.; Finn, M.; Smith, R.; Bowman, M.; Keller, P. A. Development of a CRH Type 1 Receptor Agonist: MFNA-48A. Unpublished results.
18. 1 antagonist antalarmin was administered as a 1:1 polyethoxylated castor oil/ethanol solution; see: Chan, E. C.; Falconer, J.; Madsen, G.; Rice, K. C.; Webster, E. L.; Chrousos, G. P.; Smith, R. A Corticotropin-Releasing Hormone Type 1 Receptor Antagonist Delays Parturition in Sheep. Endocrinology 1998, 139 (7), 3357-3360.
19. 1 Receptor Antagonists. J. Med. Chem. 1996, 39, 4358-4360.
20. 1 Receptor Antagonists. J. Med. Chem. 1996, 39, 4354-4357.
21. Reference 18, Supporting Information.
22. Catalyst v3.0; Molecular Simulations, Inc., Burlington, MA.
23. Sprague, P. W. Automated Chemical Hypothesis Generation and Database Searching with Catalyst. Perspect. Drug Discovery Des. 1995, 3, 1-20.
24. Kaminski, J. J.; Rane, D. F.; Snow, M. E.; Weber, L.; Rothofsky, M. L.; Anderson, S. D.; Lin, S. L. Identification of Novel Farnesyl Protein Transferase Inhibitors Using Three-Dimensioanl Database Searching Methods. J. Med. Chem. 1997, 40, 4103-4112.
25. The calculated fit function within the Catalyst program is a weighted value based on the number of features generated for each pharmacophore. Essentially, the higher the value the better the fit. Since our three hypotheses all contain five features, direct comparisons can be made.